A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 47/18 (2006.01) A61K 47/10 (2006.01) A61K 47/22 (2006.01)
Patent
CA 2566190
A pharmaceutical formulation and its use. The pharmaceutical formulation contains peroxidic species or reaction products resulting from oxidation of an alkene, such as geraniol, by an oxygen-containing oxidizing agent, such as ozone; a penetrating solvent, such as dimethylsulfoxide ("DMSO"); a dye containing a chelated metal, such as hematoporphyrin; and an aromatic redox compound, such as benzoquinone. The pharmaceutical formulation is used to effectively treat patients affected with age-related macular degeneration ("ARMD").
L'invention concerne une formulation pharmaceutique et l'utilisation de celle-ci. La formulation pharmaceutique contient des espèces peroxydiques ou des produits de réaction résultant de l'oxydation d'un alcène, tel que le géraniol, par un agent oxydant contenant de l'oxygène, tel que l'ozone; un solvant pénétrant tel que le diméthylsulfoxyde ("DMSO"); un colorant contenant un métal chélaté tel que l'hématoporphyrine; et un composé redox aromatique tel que la benzoquinone. Cette formulation pharmaceutique permet de traiter efficacement les patients atteints de dégénérescence maculaire liée à l'âge.
Hofmann Robert F.
Kirby Eades Gale Baker
Torquin Llc
LandOfFree
Use of targeted oxidative therapeutic formulation in... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Use of targeted oxidative therapeutic formulation in..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of targeted oxidative therapeutic formulation in... will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1580452